Should folic acid fortification be mandatory? No

Por Hubner, Richard A, Houlston, Richard D, Muir, Kenneth R
Publicado em 2007

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

Por Hubner, Richard A., Riley, Richard D., Billingham, Lucinda J., Popat, Sanjay
Publicado em 2011

Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy

Por Lamarca, Angela, Rigby, Christina, McNamara, Mairéad G, Hubner, Richard A, Valle, Juan W
Publicado no World J Gastroenterol (2016)

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Por Galdy, Salvatore, Lamarca, Angela, McNamara, Mairéad G., Hubner, Richard A., Cella, Chiara A., Fazio, Nicola, Valle, Juan W.
Publicado no Cancer Metastasis Rev (2016)

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

Por FAZIO, NICOLA, BUZZONI, ROBERTO, BAUDIN, ERIC, ANTONUZZO, LORENZO, HUBNER, RICHARD A., LAHNER, HARALD, DE HERDER, WOUTER W., RADERER, MARKUS, TEULÉ, ALEXANDRE, CAPDEVILA, JAUME, LIBUTTI, STEVEN K., KULKE, MATTHEW H., SHAH, MANISHA, DEY, DEBARSHI, TURRI, SABINE, AIMONE, PAOLA, MASSACESI, CRISTIAN, VERSLYPE, CHRIS
Publicado no Anticancer Res (2016)